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ABSTRACT 
Analysis of secretomes critically underpins the capacity to understand the mechanisms 
determining interactions between cells and between cells and their environment. In the context 
of cancer cell micro-environments, the relevant interactions are recognised to be an important 
determinant of tumor progression. Global proteomic analyses of secretomes are often 
performed at a single time point and frequently identify both classical secreted proteins 
(possessing an N-terminal signal sequence), as well as many intracellular proteins, the release 
of which is of uncertain biological significance. Here, we describe a mass spectrometry-based 
method for stable isotope dynamic labeling of secretomes (SIDLS) that, by dynamic SILAC, 
discriminates the secretion kinetics of classical secretory proteins and intracellular proteins 
released from cancer and stromal cells in culture. SIDLS is a robust classifier of the different 
cellular origins of proteins within the secretome and should be broadly applicable to non-
proliferating cells and cells grown in short term culture. 
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INTRODUCTION 
Protein secretion critically supports a diverse range of cellular functions including cell-cell and 
cell-matrix interactions, as well as specialized functions such as hormone or digestive enzyme 
release. The constitutive secretion of proteins is a property of all cells, while regulated 
secretion (i.e. dependent on release of preformed stores after increased intracellular Ca2+) 
occurs in specialized cells including neurons, endocrine and exocrine cells. It is now 
appreciated that an understanding of secretomes (the totality of secreted proteins) is of crucial 
importance in health and disease (1-4). For example, the secretomes of cancer and stromal 
cells contribute strongly to the cellular microenvironment that determines tumor progression 
(5). Thus, secretome studies have proven attractive both because they may provide insight 
into mechanisms of disease and because they facilitate the discovery of biomarkers that can 
be used for diagnosis, staging and monitoring of therapy.  
 
Despite considerable progress in developing methods for secretome profiling (6-8) there 
remain problematical issues in interpretation of the data. Such studies frequently identify 
“classical” secreted proteins defined by an N-terminal signal sequence but they also identify 
many intracellular proteins, the apparent secretion of which is often of uncertain significance 
and not readily discriminated from tissue leakage/cell death (9). Interpretation is further 
compounded by the fact that many studies are performed at a single time-point, such that 
kinetic differences in the release of different components of the secretome are obscured. The 
classification of secretome proteins by gene ontology (GO) terms or predictions from 
computational tools/algorithms such as SignalP (10) or SecretomeP (11) can be used to 
segregate classically secreted proteins from intracellular proteins. However, experimental 
approaches that support this classification would be of obvious advantage. For example, a 
triple-labeling, single time-point approach was adopted by Kristensen and colleagues (12), in 
which they pointed out that the extent of labeling could be used to discriminate newly 
synthesized secretome proteins and those that were mobilized from pre-existing stores. Here, 
Hammond et al.  
 
p 5 
we extend this thinking by describing a mass spectrometry (MS)-based strategy using stable 
isotope dynamic labeling of secretomes (SIDLS) that discriminates between classical 
secretory proteins and intracellular proteins within the secretome of cultured cells. The method 
differs from traditional SILAC, in which proteins are labeled for a fixed period to ensure all are 
fully labeled. Further, it differs from the single time-point pulsed SILAC approach (12) through 
dynamic labeling, in which the progressive incorporation of label into proteins is monitored 
over time. We demonstrate that a time dependency of labeling is of considerable value in the 
study of cell secretomes. A kinetic approach exploits the different labeling kinetics of classical 
secretory proteins that exhibit rapid incorporation of label compared with the much slower 
labeling of the bulk of intracellular proteins, even though some of the latter are present in the 
secretome. By monitoring the rate of incorporation of labeled amino acids into newly 
synthesized proteins as they appear in the media, we can differentiate those proteins that 
have been destined for secretion from those with low rates of labeling or low turnover relative 
to the growth rate of the cells, a feature of intracellular proteins. 
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EXPERIMENTAL PROCEDURES 
Cell culture  
Human primary cancer-associated myofibroblasts (CAMs) were derived from resected human 
esophageal squamous cancer tissue, obtained from patients as described previously (13). 
Esophageal squamous cell cancer cells, OE21, were purchased from American Type Culture 
Collection (Manassas, VA). All cells were maintained at 37°C, in 5% v/v CO2, and cultured in 
DMEM, supplemented with 10% v/v FBS as previously described (14). 
 
Stable isotopic dynamic labeling, mass spectrometry and protein identification 
Cells (1 x 106) were seeded in complete medium (DMEM) in five T75 flasks giving 80% - 90% 
confluency, per flask. The following day, the cell-conditioned medium on each flask was 
changed to fresh 37oC heavy-labeled ([13C6]-labeled L-lysine) DMEM (10 mL volume per dish, 
serum-free). At the following time intervals – 30 min, 1 h, 2 h, 6 h and 24 h – all 10 mL of now 
heavy-labeled cell-conditioned DMEM from each flask was collected for subsequent 
secretome profiling (Fig. 1A), as follows. Each medium/secretome preparation was 
centrifuged at 800 x g for 7 min to remove debris and the protein component within each was 
concentrated by mixing, with agitation, with 25 µl StrataClean resin (Agilent Technologies Ltd., 
Wokingham, UK). The resin beads were washed twice in 25mM ammonium bicarbonate 
(ambic). Each secretome-loaded StrataClean suspension was re-suspended in 80 μL of 25 
mM ambic and 5 μL of 1% (w/v) RapiGest (Waters, Hertfordshire, UK) in 25 mM ambic, prior 
to on-bead proteolytic digestion with trypsin (MS grade Trypsin Gold, Promega). The samples 
were heated at 80°C for 10 min after which proteins were reduced, by the addition of 5 μL of 
60 mM DTT at 60°C for 10 min, before being cooled prior to addition of 5 μL of 180 mM 
iodoacetamide and incubation at RT for 30 min in the dark. Trypsin (1 μg) was added and the 
samples incubated at 37°C overnight on a rotary mixer. Peptide digests were subsequently 
acidified by the addition of 1 μL of trifluoroacetic acid (TFA) and incubated at 37°C for 45 min. 
Following centrifugation at 17,000 × g for 30 min, 10 μL of each clarified supernatant (peptide 
mixture) was prepared for nano LC-MS/MS. Peptide digests (2 μL) from each sample were 
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loaded onto a trap column (Acclaim PepMap 100, 2 cm × 75 μm inner diameter, C18, 3 μm, 
100 Å) at 5 μl min−1 with an aqueous solution containing 0.1% (v/v) TFA and 2% (v/v) 
acetonitrile. After 3 min, the trap column was set in-line with an analytical column (Easy-Spray 
PepMap® RSLC 50 cm × 75 μm inner diameter, C18, 2 μm, 100 Å) (Dionex). Peptides were 
loaded in 0.1% (v/v) formic acid and eluted with a linear gradient of 3.8 – 40% buffer B (HPLC 
grade acetonitrile 80% (v/v) with 0.1% (v/v) formic acid) over 95 min at 300 nl min−1, followed 
by a washing step (5 min at 99% solvent B) and an equilibration step (15 min at 3.8% solvent). 
All peptide separations were carried out using an Ultimate 3000 nano system (Dionex/Thermo 
Fisher Scientific). The column was operated at a constant temperature of 40°C and the LC 
system was coupled to a Q-Exactive mass spectrometer (Thermo Fisher), as described 
previously (15). The Q-Exactive was operated in data-dependent mode with survey scans 
acquired at a resolution of 70,000 at m/z 200. Up to the 10 most abundant peptides of charge 
state between 2+ and 4+ were selected for fragmentation by higher energy collisional 
dissociation with an isolation window of 2.0 Th and normalized collision energy of 30. The 
maximum ion injection times for the survey scan and the MS/MS scans were 250 and 100 ms, 
respectively, and the ion target value was set to 1E6 for survey scans and 1E5 for the MS/MS 
scans. Repetitive sequencing of peptides was minimized through dynamic exclusion of the 
sequenced peptides for 20 s. 
 
Acquired MS data were searched and analyzed using Andromeda (16) and MaxQuant 1.5.8.3 
(17) against a reviewed human UniProt protein database (date: 03/09/2016 containing 20,203 
entries), using the default settings; briefly: the minimum required peptide length was seven 
amino acids long, trypsin/P was specified as the proteolytic enzyme and a single missed 
cleavage was allowed. Cysteine carbamidomethylation was set as a fixed modification and 
methionine oxidation was allowed as a variable modification. The initial precursor and 
fragment ion maximum mass deviations were set to 20 ppm and 0.5 Da, respectively. Peptide 
and protein false discovery rates (FDRs) were set to 1%, the ‘requant’ function activated and 
‘match between runs’ enabled with the default parameters. In Supplemental material 
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(Supplemental Fig. 5), we include copies of relevant figures in the main text (Figs. 3A/B, 6A/B 
and 8A/B) where the requant function was disabled, to demonstrate that although the total 
number of proteins is lower, the results and conclusions of this study are unchanged. 
 
Quantification and kinetic analysis of secretion 
To analyze the rate of incorporation of heavy stable isotope-labeled amino acids into nascent 
proteins within secreted proteins, the MaxQuant peptide-level ‘evidence.txt’ output file was 
analyzed in detail. Initially, peptides from known contaminant proteins as well as those 
generated by proteolytic mis-cleavage events (thus potentially carrying >1 labeling site) were 
omitted. Although only lysine-terminated peptides have the potential to carry a dynamic stable 
isotope label for kinetic measurements, identification of secretome proteins was based on both 
arginine- and lysine-terminated tryptic peptide matches. It would, of course, be possible in the 
future to use both labeled lysine and arginine in an effort to increase the number of kinetically 
informative peptides but the principles of the method we describe here would not change as 
a consequence. Peptide mass spectral ‘evidence data’ for secretome proteins were then split 
into two lists, according to cell-line (OE21 or CAM). 
 
For each peptide passing a 1% FDR threshold in the Andromeda search, the relative isotope 
abundance (RIA) was calculated at each time-point, if present in the MS data. RIA is 
expressed as abundance of heavy, labeled peptide (H), divided by the abundance of all (heavy 
+ light) peptide (RIAt = H/H+L). We applied a set of stringent criteria to produce high quality 
data-sets for each cell line analyzed. To model the secretome labeling trajectory, the RIA data 
for at least three time-points were used. We focused on peptides that had been identified and 
quantified, allowing RIA calculation, at more than one time-point in the labeling trajectory, so 
that we were effectively tracking their RIA behavior over time. Moreover, since the protein 
content of the secretome increases with time, we only analyzed peptide mass spectral data 
that included RIA data at 6 h and 24 h post exchange of culture medium. A small number of 
peptides were rejected from further analysis if they implied labeling profiles that could not be 
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biologically possible in this experimental system, specifically, where the calculated RIA at 30 
min or 60 min after medium exchange was greater than that after 6 h or 24 h – these are likely 
artefacts. Because proteins at t=0 are completely unlabeled and for fully labeled proteins, 
RIA=1, we fitted a simplified version of the general first order equation: 
RIAt = (1-exp(-k.t)) 
which generates the optimal fitted curve for a first order rise to plateau labeling (k) from an 
initial value of 0 to a final value of 1.0. Fitting was achieved using the nls() function in R.  
 
To assess changes in the abundance of proteins identified from the 1% FDR Andromeda 
search in our secretomes, we summed the mass spectral peptide intensity reported by 
MaxQuant for labeled (heavy) and unlabeled (light) features to obtain a quantification value. 
These intensity values represent the summed eXtracted Ion Current (XIC) of all isotopic 
clusters associated with the identified peptide sequence. If more than one peptide was 
identified and quantified per protein, we calculated the mean abundance of labeled (heavy) 
and unlabeled (light) peptide species. This was used to monitor changes in abundance of each 
individual protein in the secretome with time which, for a physiologically secreted protein, 
should increase. To calculate a measure of the flux of each protein from intracellular to 
extracellular pools/compartments, we first measured the abundance [P] secreted over an 18 
h period by subtracting the amount secreted after 6 h from that after 24 h. We then multiplied 
this with the first-order rate constant (k) at which newly synthesized protein acquired heavy 
isotopic label, to give flux (flux = k . [P]). In order to obtain protein-level kinetic data, RIA data 
for peptides belonging to the same protein were grouped together and fitted using the nls() 
function in R. Our high-quality data-sets for both cell lines were then cross-annotated with the 
output from SignalP (as described in Functional analysis, below), to explore the relationship(s) 
between labeling kinetics and predicted sub-cellular localisation. All mathematical modelling 
and data visualisations used R (v3.5.0) and ggplot2 (v2.0.1). Extraction and visualization of 
mass spectral isotopic patterns and XIC data were carried out using the ‘RforProteomics’ 
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package (1.15.0) (18). Abundance and kinetic plots are provided for every protein in 
Supplemental Material. 
 
Functional analysis 
All protein hits from the 1% FDR Andromeda search were subsequently used for subcellular 
localisation and GO enrichment analysis. The FASTA amino acid sequence for each protein 
identified in OE21 or CAM secretomes was extracted from the UniProt database and 
submitted to SignalP v4.1 (http://www.cbs.dtu.dk/services/SignalP/), to identify classically 
secreted proteins wherein a threshold SignalP D-score > 0.5 defines classical secretion, as 
described previously (10). 
 
UniProt accession numbers for all proteins in each secretome collected over the labeling 
trajectory were loaded into the R/Bioconductor package ‘clusterProfiler’ (version 3.8.0 (19)) to 
allow GO over-representation analyses. We used the ‘enrichGO’ function together with 
‘compareCluster’ to track changes in the functional enrichment profile with time, based on a 
hypergeometric distribution using a background list of all proteins in the H. sapiens annotation 
database. To remove redundant GO terms the ‘simplify’ function was applied using the “Wang” 
measure of semantic similarity (20) (similarity cut-off of 0.5), reporting only terms with the 
lowest FDR-adjusted p-values. A similar approach was taken to obtain GO functional profiles 
of our secretomes based on labeling kinetics. 
 
Western blot analysis 
Secretomes were probed by Western blot for selected classically secreted proteins, namely 
MMP1 (antibody BAF901, R&D Systems, Oxfordshire, UK), MMP3 (antibody AF913, R&D 
Systems), TGFB/TGFβig-h3 (antibody AF2935, R&D Systems) and SCG2 (antibody ab96589, 
Abcam, Cambridge, UK). In some experiments, the cells were pre-incubated for 30 min with 
10 μg.ml-1 brefeldin A (BFA; eBioscience, Ltd., Hatfield, UK), or 10 μg.ml-1 cycloheximide 
(Sigma, Dorset, UK) and/or 1 μM ionomycin (Sigma-Aldrich, Poole, UK). Proteins were 
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resolved by sodium dodecyl sulfate–polyacrylamide gel electrophoresis and processed for 
Western blotting as described previously (13). 
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RESULTS 
Experimental strategy 
Secretomes, particulary in the early periods of incubation, are low abundance and we 
concentrated proteins by adsorption onto StrataClean, a silica-based bead preparation with a 
high affinity for protein. This captures all secretome proteins, and tryptic digests can be 
conducted directly on the beads – SDS-PAGE of bead eluate after digestion confirms 
completeness of digestion (results not shown). Peptides recovered from the on-bead digests 
were then used directly for LC-MS/MS. To establish the linearity of the StrataClean bead 
capture, we completed control experiments in which fresh ‘virgin’ (v) culture media was mixed 
in different proportions (specifically, 0:100, 20:80, 50:50, 80:20 and 100:0) with media that had 
been cell-conditioned (cc) for 24 h with CAM cells (Supplemental Fig. 1, Supplemental Table 
1). StrataClean was used exactly as described in experimental procedures. The label free 
abundance of recovered proteins exhibited excellent linearity with protein load, confirming the 
quantitative performance of the protein capture method (Supplemental Fig. 1, Supplemental 
Table 1). Further, the assessment of the degree of labeling of protein captured by StrataClean 
is internally-controlled and thus independent of the quantity of protein. 
 
Kinetic parameters for secretome proteins: abundance and flux 
Each protein in a secretome has two kinetic parameters of relevance. The first is the change 
in abundance as a function of time. A protein that is actively secreted should accumulate in 
the medium, unless there is an opposing removal process that takes the protein back into the 
cell or which elicits extracellular degradation (a possibility, given the number of 
endopeptidases that are secreted from cells). Thus, abundance is not enough to define 
secretome kinetics. The second necessary parameter is flux, or the rate at which the protein 
flows from the intracellular pool to the extracellular space. Measurement of flux can also 
discriminate between classically secreted proteins and those that are released from the cell 
through necrotic or apoptotic changes, provided a labeling method is used to discriminate 
these pools. If a cell is supplied with labeled precursors, such as amino acids, the newly 
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synthesized and labeled intracellular proteins will enter and equilibrate with the unlabeled pre-
existing pool. Thus, although newly synthesized proteins are fully labeled, they are diluted by 
a large, pre-existing pool of unlabeled protein, and thus the RIA is low. Subsequent leakage 
from the cell would reflect loss of this minimally-labeled mixture. If a small proportion of this 
pool is then released from the cell, the fraction of protein molecules that are labeled will be 
low. By contrast, proteins that are classically secreted by the constitutive pathway do not have 
a large intracellular reservoir to dilute the labeling of newly synthesized molecules, so all 
labeled proteins exiting the endoplasmic reticulum/Golgi are immediately secreted from the 
cell and will exhibit rapid acquisition of complete labeling in the medium. A third class of 
proteins, those of the regulated secretory pathway which is a feature of neural, exocrine and 
endocrine cells, can have a large, stored intracellular pool in secretory vesicles, and thus, 
newly synthesized protein should enter this pool and may exhibit relatively slow labeling. We 
reasoned that these different kinetic behaviors could be used to discriminate between 
classically secreted proteins and those derived from intracellular protein leakage.  
 
Tensioned against protein turnover is the change in protein abundance. Secretome protein 
pools that expand would be expected to exhibit a rapid increase in label enrichment, consistent 
with a small intracellular pool and physiological secretion. By contrast, continued leakage of 
an intracellular protein, e.g. through cell damage, will reflect the extent of labeling of the 
intracellular pool, and unless this is an intrinsically high turnover protein, the degree of labeling 
will be low. To develop this logic further, a secreted protein pool that is static (not increasing) 
but which has a high degree of labeling must be subject to rapid removal from the extracellular 
pool (Fig. 1B). It follows that two measurements, changes in secretome protein abundance 
and the kinetic profile of labeling, could resolve proteins that are physiologically secreted from 
those that leak from the cell.  
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Rapid labeling and secretion in both cancer and stromal cells of a classically secreted 
protein but not an intracellular protein 
In this study, a cancer (OE21) cell and a stromal cell (CAM) were labeled over 24 h with a 
stable isotope-labeled amino acid in the medium and the size of the secreted pool was 
assessed by summing the abundance of labeled (heavy, H) and unlabeled (light, L) peptide 
mass spectral features over time (0.5 to 24 h; Fig. 1C, D). Concurrently, the extent of labeling 
was assessed by monitoring changes in the relative isotope abundance (RIA, expressed as 
H/[H+L]) of these features, with time. Both cell types were monitored over time for 
incorporation of [13C6]lysine, and for protein abundance. To illustrate the concept: the peptide 
SQNPVQPIGPQTPK from an established physiologically secreted protein, matrix 
metalloproteinase 1 (MMP1), could be detected in unlabeled form 30 min after incubating 
CAMs in [13C6]lysine-containing culture medium but, at this time, no labeled peptide was 
present (Fig. 1C, D). The unlabeled material defines MMP1 that was pre-synthesized prior to 
medium exchange and equilibration of the extracellular labeled amino acid with the 
intracellular tRNA pool. Over time, there was a progressive increase in labeled MMP1, 
highlighted by the shift in the relative peak heights of either XICs (Fig. 1C) or peptide precursor 
ion isotopic envelopes (Fig. 1D), as well as in change in RIA with time (RIAt, Fig. 2A, red line). 
However, intracellular proteins, of which tubulin beta 3 (TBB3) is a representative example, 
incorporated virtually no label during the same period (Fig. 2A, blue line). Moreover, a 
comparison of the quantified abundance (summing both labeled and unlabeled peptides to 
obtain the total pool) revealed that whilst the output of MMP1 increased steadily over the 
period of the experiment, the abundance of TBB3 remained relatively static or even declined 
(Fig. 2B). 
 
Secretome constituents meeting the criteria for kinetic analysis 
We established a dataset of secretome proteins upon which a rigorous analysis of secretory 
kinetics might be made. After removing peptide spectrum matches (PSMs) from known 
contaminant proteins (included in the MaxQuant installation by default), we had a dataset with 
Hammond et al.  
 
p 15 
92,480 PSMs: 48,933 in OE21 secretome samples corresponding to 2,109 unique proteins 
and 43,547 in CAM samples corresponding to 1,815 unique proteins. Approximately 9% of 
total PSMs (8,274) were generated by proteolytic mis-cleavage events and although those 
containing lysine residues could also report on labeling extent, they were excluded in this 
analysis. Arginine-terminating PSMs accounted for approximately 40% of the total (OE21, 
19,243; CAM, 17,566) and were used for protein identification purposes but not for 
measurement of label incorporation. The remaining 55,671 PSMs (OE21, 29,690; CAM, 
25,981) were lysine-terminated with a single instance of this amino acid; these mapped to 
1,751 (OE21) and 1,484 (CAM) unique proteins. Further application of the stringent filtering 
criteria described in the experimental procedures section yielded 910 individual proteins from 
OE21 cells (RIAt data generated from 13,585 PSMs) and 549 proteins from CAMs (RIAt data 
generated from 11,313 PSMs). Pre- and post-filtered RIAt datasets can be found in 
Supplemental Table 2. 
 
Classically secreted proteins exhibit distinct secretory kinetics 
For each protein in the reduced and filtered dataset, the labeling vector was measured as a 
first order rate constant (k) defining the rise to plateau labeling and, if appropriate, exchange 
into a pre-existing, unlabeled intracellular pool. Moreover, the quantified abundance (summing 
both labeled and unlabeled peptides to obtain the total pool) was used to determine the rate 
of pool expansion. These two parameters were then used to discriminate classically secreted 
proteins from intracellular proteins that were externalized by leakage. Complete labeling 
trajectory and abundance curves for individual proteins from both CAMs and OE21 cells are 
provided in the Supplemental material (Supplemental Fig. 2 [CAM] and Supplemental Fig. 3 
[OE21]; red plots – labeling kinetics; blue plots – abundance). Many proteins were rapidly 
labeled and after a short period the RIAt reached unity. By contrast, other proteins were barely 
labeled in the same time frame. Further exploration of the data indicated that well known 
classically secreted proteins (e.g. MMP1, MMP2, MMP3, TGFig-h3) incorporated [13C6]lysine 
rapidly whilst known intracellular proteins (e.g. BAG3, COF1, SYSC, TBB5) were labeled 
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minimally. In addition, the abundance in the cell medium of classically secreted proteins 
increased while that of intracellular proteins remained either constant or declined (for 
abundance data-sets for both CAM and OE21 cells, see the blue plots in Supplemental Fig. 2 
and Supplemental Fig. 3, respectively). These observations therefore support the hypothesis 
that the rate of labeling of a protein (k) is a reliable indicator of physiological secretion, i.e. 
proteins destined for secretion by virtue of an N-terminal signal sequence and with no large 
intracellular pool to dampen the incorporation of label. High k values are associated with those 
proteins that were operationally defined as secreted, whether based on direct knowledge or 
through bioinformatically-derived (SignalP) prediction (Fig 3A and 3B, see also Supplemental 
Fig. 5A and 5B with requant disabled). The SignalP D-cutoff score is a combined value from 
both signal-peptide and cleavage site prediction networks. The default thresholds resulting in 
a positive prediction of a signal peptide are 0.5 or 0.45 for eukaryotic proteins with or without 
a transmembrane domain, respectively (10). Based on our biology-driven SIDLS approach, 
these thresholds appear to be accurate (see grey dashed lines in Fig. 3A, CAMs; and 3B, 
OE21 cells). 
 
Matching secretory kinetics and SignalP scores 
To relate secretome kinetics to a protein classification we divided the secretome data into 
proteins with a SignalP score of >0.5 (classical secretory proteins) compared with those 
without (<0.5). From the secretomes of the two cell types it was readily possible to identify six 
different protein populations, namely classically secreted or not, those that were common to 
the two cells or those exclusive to OE21 or CAMs (Fig. 4). After 6 h of labeling, the RIA of 
CAM secretome proteins with SignalP >0.5 was clearly distinguishable from those with <0.5. 
This was also evident although less pronounced in OE21 cells at 24 h (Fig. 5). Rates of label 
exchange differed for individual proteins (Fig. 6A, CAMs; and Fig. 6B, OE21 cells) but the 
discrimination based on SignalP score was nonetheless impressive. There are proteins, 
however, that appear to acquire label very quickly, but which are not classically secreted 
proteins (i.e. with SignalP scores <0.5; for e.g., see dashed lines in Fig. 6A and 6B, see also 
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Supplemental Fig. 5C and 5D with requant disabled). These initially raised concerns to us but 
their RIAt data are suspicious in that they show an instant rise to plateau without any 
subsequent increase over time. Detailed inspection of the peptide-level chromatography and 
mass spectrometry data for these proteins revealed them to be erroneous measurements 
derived from mis-assignment of heavy/light peptide features by MaxQuant. In fact, in all these 
cases, there was no tandem MS evidence of both light and heavy features, and we believe 
these are anomalous data-points. The association between SignalP >0.5 and k >0.02 h-1 
(combined k for SignalP >0.5 in OE21, Fig. 6B, red line) was highly significant for both CAMs 
and OE21 cells (Fisher exact text, p<0.001 in both cases). Combined fits of all proteins, in 
each cell type, sub-classified based on SignalP score (> or <0.5), indicated a >10-fold 
difference in the rate of label exchange (k) in CAMs (Fig. 6C), and an approximately 5-fold 
difference in OE21 cells (Fig. 6D). 
 
A cut-off of k ≥ 0.1 h-1 for the kinetics of a classically secreted protein was initially selected 
based on an empirical assessment of the data. Indeed, in support of this, inspection of Fig. 
6C (red line) shows the predicted k for all proteins with SignalP >0.5 in CAMs was actually 
quite close to this cut off, i.e. 0.058 h-1. However, the selection of the cut-off in k to differentiate 
classically secreted proteins may vary for different cell types depending on their biology. For 
example, there were lower rates of label exchange in the cancer cell line (OE21; Fig. 6D). 
Alternative approaches to defining the cut-off may prove useful in comparative studies 
between cell types (21). Taking a combined fit value of each secretome sub-classified by 
SignalP > or <0.5, which is valid also based on its relationship to k (Fig. 3), identified a distinct 
group of 108 / 549 (CAMs) and 57 / 910 (OE21) proteins that are ‘true’ physiologically secreted 
proteins. 
 
Validation of the kinetics of classically secreted proteins 
To determine whether the SIDLS kinetic profiles were compatible with those derived by other 
methods, we used orthogonal analysis by Western blots to define the kinetic responses of 
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three representative classically secreted proteins, MMP1, MMP3 and transforming growth 
factor-beta-induced protein ig-h3 (TGFBI / TGFig-h3), following pharmacological treatments 
that arrest protein secretion. When translation was inhibited in CAMs with cycloheximide, the 
accumulation in the medium of MMP1 and TGFig-h3 was already inhibited at 1 h and for 
these two as well as MMP2 was very clearly inhibited at 4 h (Fig. 7A, left). Similarly, using the 
ER-to-Golgi transport inhibitor, brefeldin A (BFA), to block progression along the secretory 
pathway, the appearance of MMP1 was suppressed at 1 h and for all three proteins at 2 h 
(Fig. 7A, right). The rate of appearance and abundance of all three proteins in the secretome 
measured using immunoblotting closely mirrors that determined by SIDLS (Fig. 7B). 
 
Application of SIDLS to proteins exhibiting regulated secretion  
Constitutively secreted proteins predominate in the secretomes of the two cells studied here. 
However, stromal myofibroblasts including CAMs may exhibit a modest regulated secretory 
pathway (22) and in this context it is interesting that a marker of the pathway, secretogranin-
2 (SCG2), was identified and exhibited rapid label incorporation (k = 0.274 h-1). Immunoblotting 
confirmed that secretion of SCG2 was stimulated by a short (30 min) stimulation with 
ionomycin, consistent with calcium-evoked exocytosis and the response was resistant to 
cycloheximide and BFA, consistent with release from storage vesicles (Fig. 7C). Thus, SIDLS 
can also be applicable to proteins of the regulated secretory pathway. The kinetics of labeling 
of these proteins in the medium may be slower than for constitutively secreted proteins 
although this may be offset to a substantial extent for those regulated secretory proteins that 
exhibit preferential secretion of newly synthesized material (23, 24).  
 
Meta-analysis of classically secreted proteins in the CAM secretome 
Classically secreted proteins included representatives of several important classes of secreted 
protein, notably extracellular matrix (ECM) proteins such as TGFB/TGFig-h3, proteases (e.g. 
MMP1, MMP3, C1R), protease inhibitors (e.g. TIMP1, TIMP2, SERPINE1, SERPINE2), 
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chemokines (e.g. RARRES2), cytokines (e.g. the growth factors, VEGFC and CTGF) and 
growth factor-associated proteins (e.g. IGFBP3, -4, -5, -6), some of which have already been 
characterized in previous studies of myofibroblast secretomes (14, 22, 25). When flux is 
plotted against estimated k, this sub-set is readily distinguishable (Fig. 8, selected examples 
are highlighted, see also Supplemental Fig. 5E and 5F with requant disabled). 
 
Using a SignalP D-score < or >0.5, in isolation, as a classifier of secretion (Fig. 9A [CAM] and 
Fig. 9C [OE21]), GO over-representation analysis revealed molecular function (GOMF) terms 
linked with binding to multiple ECM components for secreted proteins (SigP >0.5). Non-
secreted proteins, however, showed an enrichment with terms associated primarily with 
translation and cell structure, consistent with the idea that these are simply ‘leaked’ proteins 
that function in these intracellular processes. Utilising our data-driven, SIDLS-determined 
classification of the secretome, in combination with SignalP (see Fig. 6C and 6D) to separate 
the secretome into a ‘high k’ group (k > combined fit for SignalP >0.5 proteins) and a ‘low k’ 
group (k < combined fit for SignalP >0.5 proteins) reveals an almost identical pattern of GOMF 
terms (Fig. 9B [CAM] and 9D [OE21]), adding further confidence to our SIDLS-mediated 
approach to secretome classification. 
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DISCUSSION 
We describe a dynamic stable isotopic labeling- and mass spectrometry-based approach to 
characterise the physiological secretome of any cell that can be maintained in culture. Unlike 
traditional SILAC approaches, our Stable Isotope Dynamic Labeling of Secretomes (SIDLS) 
method exploits the kinetics of exchange from light-to-heavy stable isotopic labeling that 
occurs with protein synthesis de novo over relatively short labeling trajectories, thus 
dispensing with the need for exogenously-added serum factors required in more long-term cell 
cultures. This is beneficial as serum often contains an abundance of factors that influence the 
behavior and physiology of the culture system. SIDLS can confidently discriminate the 
secretion kinetics of physiologically-relevant classical secretory proteins from intracellular 
proteins that are released from cells either through damage during cell culture, apoptosis or 
‘leakage’. It is therefore a powerful classifier of the different cellular origins of proteins within 
the secretome and should be broadly applicable, allowing secretome characterisation of non-
proliferating cells and cells only viable in short term culture. Embedding new knowledge of the 
rate of synthesis of the secretome constituents improves upon previously described 
approaches that rely on either the time-consuming labeling of cells to completion with heavy 
isotopic labels (traditional SILAC approaches), complex click chemistry approaches, or a 
combination of the two (12, 26-29). 
 
Across two different cell lines we obtained global secretome identification of over 2,000 
proteins and, in parallel, definitively determine the dynamic secretome behavior of a large 
proportion of these proteins, helping define their true intracellular origin and physiological role 
(see Supplemental Tables 2 and 3 for complete data-sets). As expected, classical secreted 
proteins show a shift in RIA from 0 towards 1 over time (as exemplified by MMP1 in Fig. 2A, 
red line). This is especially true in the non-transformed cells (CAMs), taking the SignalP score 
as a classifier of secretion or not (Fig. 5A). Our dynamic labeling strategy, combined with 
assessment of total abundance in the secretome, allowed us to distinguish, with high 
confidence, secreted protein assignments from erroneous measurements borne out of 
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chromatographic and MS errors (e.g. co-eluting peptide MS isotopic envelopes skewing RIA 
calculations), as logic dictates that the total abundance of any secreted protein in the 
secretome must increase with time. Several proteins that appear to be secreted readily, but 
which have no known extracellular function, fall into this bracket (e.g. RRP12 in OE21 cells; 
GRHL1 and AL9A1 in CAMs; CHMP3 in both OE21 cells and CAMs). 
  
In our dataset, some classically secreted proteins show near identical behavior across both 
cell-lines (see Supplemental Fig. 4). Although small, this list of proteins identified in both CAM 
and OE21 secretomes shows that in general, a commonality exists in the secretome behavior 
of proteins between stromal and cancer cells that exist within the same microenvironment. But 
several proteins were removed from our data-sets during stringent filtering of the RIAt data. 
Indeed, some other classical secreted proteins, for e.g. additional members of the MMP family, 
did not meet our stringent filtering criteria – for example, where tandem MS evidence existed 
for both light and heavy peptide features, but only at one time point in the labeling trajectory 
(all protein data is included in the raw data in Supplemental Tables 2 and 3). More in-depth 
proteomic analyses, for e.g. adopting fractionation approaches of each secretome sample, 
would increase the number of proteins identified allowing improved cross-comparison(s) to be 
made. However, it must be noted that, in general, the relationship between the rate of labeling 
in OE21 cancer cells and rate of labeling in CAMs, for common proteins, is not a strong 
correlation. Much clearer is a generally lower rate of incorporation of label into newly 
synthesized protein in the cancer cells (OE21), indicative of defective protein synthesis and/or 
trafficking though the secretory system in cancer. 
 
One of the main advantages of SIDLS is that it provides an orthogonal perspective to 
secretome dynamics. By tracking the appearance of label in secreted proteins, it is possible 
to build a profile of the speed and duration of response of individual proteins and resolve true 
secreted proteins from low level intracellular leakage. The marked consonance between 
proteins that would be labeled as secreted through a high predictive score of a signal peptide 
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and rapid labeling gives a convincing confirmatory perspective on the secretome. For this 
analysis, we have been very stringent in the retention of proteins, and those for which 
abundances were too low for recovery by data-dependent acquisition approaches would be 
recovered by more targeted methods, such as selected reaction monitoring (30). It is not too 
bold to imagine that the use of different labeled precursors in a pulse-labeling strategy would 
provide new insights into the interaction of co-cultures of cells mediated by their secretomes. 
Thus, inclusion of the simple expedient of dynamic labeling of secretomes will greatly increase 
the confidence with which such secretomes are studied.   
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The mass spectrometry proteomics data for the SIDLS dynamic labeling aspect of this study 
have been deposited to the ProteomeXchange Consortium via the PRIDE (31) partner 
repository with the dataset identifier PXD007231. Equivalent data for the linearity of protein 
capture by StrataClean are deposited to ProteomeXchange too, with the identifier 
PXD009838. The output of the MaxQuant searches of the SIDLS dynamic labeling proteomics 
data are available using MS-Viewer (http://msviewer.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msviewer), using the search key identifier: 88dyh3qzvc . All annotated 
spectra can be accessed here. That for the StrataClean linearity experiment is also available 
using MS-Viewer using the search key idenitifier: hjhr9jxzpk. 
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FIGURE LEGENDS 
Fig. 1. Concept, design and analytical structure of the study. 
Panel A, Dishes of cells (OE21 or CAMs) were initially seeded and established in standard 
growth medium (DMEM) before this was exchanged for SILAC DMEM containing heavy stable 
isotope-labeled lysine ([13C6]lysine). Cell-conditioned SILAC DMEM was then collected at the 
indicated times (1 dish per time-point) for up to 24 h. Protein secreted from the cells was 
concentrated using StrataClean and digested into peptides for subsequent analysis by LC-
MSMS. Panel B, Schematic diagram showing how measuring changes in the abundance of 
secreted protein(s) and their extent of labeling with heavy stable isotopic amino acids over 
time will resolve proteins that are physiologically secreted from those that leak from the cell. 
The rate of incorporation of [13C6]lysine into nascent proteins within the secretome was 
determined from the LC-MSMS data; C, shows representative extracted ion currents (XICs) 
and D, isotopic envelopes for the peptide SQNPVQPIGPQTPK from matrix metalloproteinase 
1 (MMP1). Measuring the rate of incorporation of heavy isotope (expressed as the relative 
isotope abundance, or RIA), with time (RIAt), allows secretion dynamics to be determine for 
every detected protein secreted. 
 
Fig. 2. Representative dynamic behavior of a classically secreted protein (MMP1) and 
an intracellular protein (TBB3). 
Panel A, Secreted proteins acquire heavy label quickly since there is no intracellular pool to 
dilute/delay acquisition of label. This is exemplified by the rapid rise towards RIA of 1, as 
shown by MMP1 (red line). Panel B, The abundance of a secreted protein should increase 
continuously with time, as also demonstrated by MMP1 (red line). Opposing behaviors can be 
seen for the intracellular protein TBB3 (A, B, blue lines). 
 
Fig. 3. Rates of label exchange for individual proteins discriminated on the basis of 
SignalP score. 
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The first order rate constant (k) of incorporation of [13C6]lysine into nascent proteins within the 
CAM (A) or OE21 (B) secretome was plotted as a function of the SignalP score. Symbols are 
color-coded on the basis of SignalP score, from 0 = dark blue, through to the maximum score 
of 1 = red. SIDLS-determined predictions of secretion on the basis of rate (k) of light-to-heavy 
label incorporation closely match those predicted by SignalP, with the vast majority of proteins 
showing high rates of label exchange (> 0.05) also having high SignalP scores, typically >0.5. 
An equivalent plot with the MaxQuant requant function disabled is provided in Supplemental 
Material. 
 
Fig. 4. Classification of proteins on the basis of secretome behavior. 
Monitoring the abundance of each protein in the 24 h secretomes of the two cell types (OE21 
and CAM) allows the identification of six different protein populations; classically secreted 
(SignalP score >0.5, large red points) or not (SignalP score <0.5, small grey points), and either 
common to the two cells (blue dashed circled) or exclusive to OE21 or to CAMs, as highlighted 
on the plot. 
 
Fig. 5. Time-dependent changes in peptide relative isotope abundance (RIA). 
For all high quality [13C6]lysine-labeled peptides at the indicated times, the RIA, expressed as 
the ratio H/(H+L) was calculated and plotted as a distribution curve using kernel density 
estimation. For proteins that do not contain a signal peptide (SignalP <0.5), peptides remain 
almost entirely unlabeled over the total trajectory of the study (blue lines). Peptides from 
secreted proteins (SignalP >0.5), however, demonstrate a clear transition from largely 
unlabeled to extensively labeled as a consequence of protein turnover/label exchange. This 
is especially true in the stromal CAM cell line (left hand panels), but is also evident although 
less pronounced in cancer (OE21) cells. The dotted lines define the maximum possible RIA 
that the system can attain. 
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Fig. 6. Rates of label exchange for individual proteins and complete secretomes, 
discriminated on the basis of SignalP scores. 
First-order rate constants at which newly synthesized proteins acquire heavy isotopic label, 
for every protein in the CAM (Panel A) and OE21 (Panel B) secretomes. Physiologically-
secreted proteins (SignalP >0.5; red lines) clearly acquire new [13C6]lysine at a higher rate 
compared to intracellular proteins that merely ‘leak’ from the cell (SignalP <0.5; blue lines). 
Some proteins with low SignalP scores appear to be readily secreted or have very high 
turnover (blue dashed lines); however, manual inspection of the raw MS data for these 
proteins revealed them to be artefacts (see main text for explanation). Relating ‘global’ 
secretome kinetics to protein classification on the basis of a computational prediction of the 
presence or not of a signal peptide (SignalP score), reveals an impressive discrimination in 
CAMs (Panel C) and, to a lesser extent, in cancer cells (Panel D), thus raising questions about 
the secretome behavior of cells in vivo in the tumor microenvironment. An equivalent plot with 
the MaxQuant requant function disabled is provided in Supplemental Material. 
 
Fig. 7. Validation of the kinetics of classically secreted proteins by Western blotting. 
Panel A, The kinetic behavior of three representative classically secreted proteins, MMP1, 
MMP3 and TGFBI/TGFig-h3, following pharmacological blockade of secretion in CAMs, were 
validated using a standard immunoblotting approach. When translation was inhibited with 
cycloheximide, the accumulation in the medium of MMP1 and TGFig-h3 was already reduced 
at 1 h. For these two proteins (and MMP2), secretion was clearly inhibited at 4 h. Similarly, 
upon perturbation of secretion using brefeldin A (BFA), the appearance of MMP1 was 
suppressed at 1 h and of all three proteins from 2 h. Panel B, The kinetics of secretion of 
MMP1, MMP3 and TGFig-h3 determined by SIDLS clearly match those determined by the 
orthogonal approach of Western blotting. Panel C, Evidence that SIDLS can discern proteins 
of the regulated secretory pathway. Western blot confirmation that secretion of secretogranin-
2 (SCG2), an established marker of a minor, endocrine-like secretory phenotype known to be 
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present in stromal myofibroblasts (CAMs), was stimulated by a short (30 min) stimulation with 
ionomycin. This is consistent with calcium-evoked exocytosis and the response was resistant 
to cycloheximide (left) and BFA (right), supporting the idea that this represents release from 
intracellular storage vesicles. 
 
Fig. 8. Relationship between k and flux of protein from intracellular to extracellular 
pools. 
A surrogate measurement of flux into the extracellular protein pool was determined by 
calculating, flux = k . [P], where k is first-order rate constant at which newly synthesized protein 
acquired heavy isotopic label and P is the amount of protein secreted over an 18 h period. 
Symbols are color-coded on the basis of SignalP classification (>0.5 = red; <0.5 = blue) with 
alpha transparency shading according to the score from SignalP predictions (from 0, high 
transparency – to 1, low transparency). Panel A, CAMs; Panel B, OE21 cells. Selected 
proteins of interest in tumor biology are highlighted. An equivalent plot with the MaxQuant 
requant function disabled is provided in Supplemental Material. 
 
Fig. 9. Functional analysis of the secretome. 
GO enrichment analysis was performed using the ‘compareCluster’ function in the 
R/Bioconductor package ‘clusterProfiler’. All proteins identified in the CAM (Panel A, B) or 
OE21 (Panel C, D) secretomes were loaded simultaneously in clusters based upon either their 
classification according to SignalP (D-score < or >0.5, Panel A, C) or their classification 
according to SIDLS (‘high k’ vs ‘low k’, Panel B, D) and statistically over-represented GOMF 
terms of each protein set determined (hypergeometric test pvalueCutoff, p = 0.000001 for 
CAM, p = 0.01 for OE21). To aid visualisation and interpretation of the data, redundant GO 
terms were removed using the ‘simplify’ function (as described in Experimental Procedures) 
and the most over-represented GOMF terms plotted as dotplots. GO terms linked with binding 
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to multiple ECM components are over-represented in the secreted protein clusters (SigP >0.5 
and ‘high k’). Non secreted proteins, however, showed an enrichment with terms associated 
primarily with translation and cell structure (SigP <0.5 and ‘low k’). Abbreviations: bdg. = 
binding; struct. = structural; constit. = constituent; act. = activity; transl. = translation; dep. = 
dependent; mol. = molecular. 
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